Sigrid K. Fey

机构：German Cancer Research Center, Heidelberg University, DKFZ-ZMBH Alliance, Heidelberg Institute for Stem Cell Technology and Experimental Medicine · ORCID：0009-0007-3667-513X

发表论文 52 篇 · 总被引 763 次 · h-index 9

代表论文

• Dark force rising: Reawakening and targeting of fetal-like stem cells in colorectal cancer (2024 · Cell Reports · 被引 29)
• KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo (2024 · Nature Communications · 被引 19)
• KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition (2024 · Cancer Research · 被引 9)
• TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer (2026 · Nature · 被引 1)
• Supplementary Figure 1 from <i>KRAS</i> Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition (2026)
• Supplementary Figure 4 from <i>KRAS</i> Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition (2026)